Trasylol, Injektions-/Infusionslösung

7680388370280 CH-38837 Injektions-/Infusionslösung
Trasylol, Injektions-/Infusionslösung
Trasylol, Injektions-/Infusionslösung
Trasylol, Injektions-/Infusionslösung
1 / 3
google

Article details

Package size
1 x 50 mL
Selling units
50
Measure
Durchstechflasche(n)
Galenic form
Injektions-/Infusionslösung
Galenic group
Unknown

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
08/01/2025
Summary of Product Characteristics
Français
08/01/2025
Summary of Product Characteristics
Italien
08/01/2025

Detailed composition

Substance Quantity Type Category
(N/A)
277.8 UPE Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
177.0 MG Substance HBESI
(N/A)
- Substance HNIDK

Authorization holder

Nordic Pharma GmbH

8050 Zürich

Authorization information

Swissmedic authorization number
38837
Drug name
Trasylol, Injektions-/Infusionslösung
Galenic form
LSIN
ATC Code
B02AB01
Authorization status
Z
Dispensing category
B
First authorization
16/03/1977
Authorization expiration date
31/12/9999
IT Number
06.06.0.
Domain
Human medicine
Field of application
Zur Verminderung des Blutverlustes bei Operationen mit extrakorporalem Kreislauf

Package details

Description (FR)
TRASYLOL sol perf 500000 UIK flac 50 ml
Description (DE)
TRASYLOL Inf Lös 500000 KIE Durchstf 50 ml
Market launch
16/03/1977
Narcotic (BTM)
No

Other package sizes (1)

TRASYLOL sol perf 2 mio U 200 ml
None None
GTIN: 7680388370440
Not in V1